ÂÜÀòÂÒÂ×

Victoria Meissner, MD, currently serves in Healthcare Investment Banking at H.C. Wainwright & Co., LLC since January 2025. Prior to this role, Victoria held positions as Head of Investor Relations and Vice President of Strategy at BioNTech SE from April 2023 to January 2025, and worked in Healthcare Investment Banking at Jefferies and Oppenheimer & Co. Inc. from December 2021 to April 2023 and January 2021 to December 2021, respectively. With experience as Vice President at Westwicke and Cove Capital, LLC, specializing as a Senior Analyst in Life Sciences, Victoria has a strong background in the healthcare sector, particularly in medical technology and biotechnology. Earlier roles include positions in investor relations at The Ruth Group and Russo Partners, as well as a Medical Doctor and PhD researcher at UI Health focused on clinical islet transplantation. VictoriaMeissner holds a Doctor of Medicine from the Medical University of Vienna and a Doctor of Philosophy in Microbiology and Immunology from the University of Illinois Chicago.